Published in J Clin Endocrinol Metab on July 21, 2010
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence. Aging Dis (2011) 1.33
Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. J Gerontol A Biol Sci Med Sci (2013) 1.25
Workplace based mindfulness practice and inflammation: a randomized trial. Brain Behav Immun (2012) 1.08
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective. Drug Des Devel Ther (2010) 1.06
The effects of weight cycling on lifespan in male C57BL/6J mice. Int J Obes (Lond) (2012) 0.91
Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J Aging Res (2011) 0.83
Sex and inflammation in respiratory diseases: a clinical viewpoint. Biol Sex Differ (2013) 0.82
Elevated systolic blood pressure in male GH transgenic mice is age dependent. Endocrinology (2013) 0.81
Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing (2016) 0.81
C-reactive protein and cognition are unrelated to leukoaraiosis. ScientificWorldJournal (2014) 0.75
C-Reactive Protein and Frailty in the Elderly: A Literature Review. J Clin Med Res (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92
Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32
The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet (1996) 4.90
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation (2000) 4.81
Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation (2003) 4.67
Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem (2008) 4.08
Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J Clin Endocrinol Metab (2001) 3.05
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation (2005) 2.48
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Longevity is moderately heritable in a sample of Danish twins born 1870-1880. J Gerontol (1993) 2.30
C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost (2006) 2.25
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med (2008) 2.01
C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J (2002) 1.99
Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation (1999) 1.96
Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity (Silver Spring) (2009) 1.88
Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev (2007) 1.82
How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost (2009) 1.63
Inflammation biomarkers and near-term death in older men. Am J Epidemiol (2007) 1.52
Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr (2009) 1.51
Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care (2004) 1.50
Heritability of life span in the Old Order Amish. Am J Med Genet (2001) 1.46
C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol (2003) 1.43
Cardiovascular biology of interleukin-6. Curr Pharm Des (2009) 1.35
C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol (2000) 1.30
The genetics of human longevity. Ann N Y Acad Sci (2006) 1.30
New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab (2003) 1.27
C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation (2006) 1.25
Accelerated failure time models provide a useful statistical framework for aging research. Exp Gerontol (2008) 1.24
Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci (2007) 1.16
Hormone replacement therapy, inflammation, and hemostasis in elderly women. Arterioscler Thromb Vasc Biol (1999) 1.04
C-reactive protein and coronary disease: is there a causal link? Circulation (2009) 1.03
Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci (2008) 1.01
Biomarkers in peripheral arterial disease patients and near- and longer-term mortality. J Vasc Surg (2010) 1.00
High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: results from The 90+ Study. J Am Geriatr Soc (2009) 0.96
Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions. Curr Drug Targets (2003) 0.90
[Adipocytokins, obesity and development of type 2 diabetes]. Med Sci (Paris) (2005) 0.78
Inflammation and the aging process: devil or angel. Nutr Rev (2007) 0.78
[Role of tumor necrosis factor (TNF) and interleukin-6 (IL-6) in the pathogenesis of late complications of menopause. Effects of hormone replacement therapy on TNF and IL-6 expression]. Pol Merkur Lekarski (2005) 0.76
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc (2007) 3.15
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80
Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care (2007) 2.71
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69
Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63
Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation (2008) 2.56
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol (2013) 2.44
Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res (2005) 2.44
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care (2009) 2.36
The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci (2006) 2.35
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care (2002) 2.28
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol (2008) 2.26
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med (2007) 2.17
Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol (2010) 2.15
Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population. Diabetes Care (2002) 2.10
Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension (2011) 2.09
Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study. Circulation (2002) 2.06
Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism (2002) 2.04
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med (2004) 1.95
Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care (2009) 1.95
Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93
Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study. J Bone Miner Res (2005) 1.89
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88
Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol (2006) 1.86
Hyperkyphotic posture predicts mortality in older community-dwelling men and women: a prospective study. J Am Geriatr Soc (2004) 1.86
Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol (2006) 1.85
Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol (2012) 1.84
Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study. Am J Kidney Dis (2011) 1.83
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82
Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause (2009) 1.80
Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol (2010) 1.80
Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause (2003) 1.77
Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab (2003) 1.76
Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res (2004) 1.76
Predictors of heart failure among women with coronary disease. Circulation (2004) 1.74
Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med (2006) 1.72
Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res (2002) 1.70
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab (2004) 1.70
Sexual activity and satisfaction in healthy community-dwelling older women. Am J Med (2012) 1.70
Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med (2003) 1.68
Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol (2004) 1.68
Gender differences in nighttime sleep and daytime napping as predictors of mortality in older adults: the Rancho Bernardo study. Sleep Med (2012) 1.67
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol (2008) 1.64
Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res (2002) 1.58
Hyperkyphotic posture and poor physical functional ability in older community-dwelling men and women: the Rancho Bernardo study. J Gerontol A Biol Sci Med Sci (2005) 1.57
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. J Natl Cancer Inst (2008) 1.56
Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. Menopause (2011) 1.56
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes (2013) 1.55
Hyperkyphotic posture and risk of injurious falls in older persons: the Rancho Bernardo Study. J Gerontol A Biol Sci Med Sci (2007) 1.54
Lower urinary tract symptoms increase the risk of falls in older men. BJU Int (2009) 1.53
Race and ethnic variation in proximal femur structure and BMD among older men. J Bone Miner Res (2008) 1.53
Bone mineral density and clinical hand osteoarthritis in elderly men and women: the Rancho Bernardo study. J Rheumatol (2002) 1.52
A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol (2010) 1.52
The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab (2009) 1.52
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men. BJU Int (2009) 1.52
BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res (2011) 1.51
Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause (2011) 1.51
Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care (2006) 1.50
Reductions in glucose among postmenopausal women who use and do not use estrogen therapy. Menopause (2013) 1.50
Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care (2004) 1.50
Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology (2008) 1.48
Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc (2008) 1.48
An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med (2004) 1.48
Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care (2008) 1.48
Association between the ankle-brachial index and carotid intimal medial thickness in the Rancho Bernardo Study. Am J Cardiol (2006) 1.47
When is it appropriate to prescribe postmenopausal hormone therapy? Menopause (2006) 1.46
Body mass index and quality of well-being in a community of older adults. Am J Prev Med (2004) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes (2007) 1.45